Mountain View, Calif.-based start up Alivecor Inc. started out with a strong consumer focus for its FDA-cleared mobile electrocardiogram (ECG) technology Kardia, aiming particularly for people with known or suspected atrial fibrillation. But it's been increasingly moving toward a more traditional path in relation to treatment by health care providers and reimbursement from payers. Read More
